No one with any sense of the international community was surprised when we discovered that Russia’s military was misbehaving in Ukraine, but the extent to which the Kremlin is willing to play dirty is turning unnerving.
Not only are the rapidly losing Russian troops committing horrid atrocities as they drop their guns and run, but Russian President Vladimir Putin has consistently threatened nuclear war against anyone who dares to try to stop him.
And while the outward appearance of many of the world’s government’s has thrown a dismissive tone Putin’s way, there are indications that they’re taking him a little more seriously than they are letting on.
The US government has purchased a significant supply of radiation-injury drugs as the Russian president threatened the use of nuclear weapons.
A $290 million procurement of the drug Nplate, to treat acute radiation syndrome (ARS), was announced by the US Health and Human Services (HSS).
The government confirmed it was the first purchase of the drug, manufactured by the California pharmaceutical company Amgen.
The feds weren’t trying to sound the alarm, however.
The US government said the procurement of Nplate was not in response to the war in Ukraine.
An HSS spokesman told The Telegraph: “This is part of our ongoing work for preparedness and radiological security. It has not been accelerated by the situation in Ukraine.”
It is understood the HSS has been working with Amgen, and similar companies, for some years.
Russian nuclear equipment appears to be on the move toward Ukraine this week, not long after the aforementioned “not a bluff” moment.
